Inventory and Analysis of Biotech Programmes and Related Activities in All Countries Participating in the Biotechnology Programme Branche: Chemische Industrie Technikfeld: Bio- & Gentechnik Kurzbeschreibung: Since the beginning of the eighties, biotechnology has been the focus of national and European Community R&D stimulating programmes. This has led to a broad network of publicly and privately financed research institutes and universities working in the field of biotechnology. Biotechnology per se is rather broad and heterogeneous, including several different types of research and techniques, related scientific disciplines and application areas. Although most member states regularly produce some sort of overviews of biotech R&D, these overviews are not complete and in most cases are produced from the perspective of specific organisations and with specific goals. All in all these overviews are not easily comparable and do not provide an adequate basis for the European Commission to co-ordinate their programmes in the field of biotechnology. Against this background the project aims at providing an overview of biotech R&D in countries participating in the EC Biotechnology Programme 1994-1998. Results: The project provides a comprehensive and comparable analysis of biotechnology funding policies based on a common taxonomy of biotechnology for all European member states, Norway and Switzerland. The results indicate that specific biotechnology R&D programmes, comprising instruments like project funding, funding of biocentres, centres of excellence, directed core support for biotech institutes, stimulation of technology transfer and others, cover approximately 30 % of all public spending on biotechnology between 1994 and 1998 in European countries. More than 50 % of all public biotechnology funding in European countries is channelled via non-policy-directed measures. These include open call systems of research councils or block grants to research institutes which in some cases develop autonomously their own internal programmes. In a number of cases governmental research institutes develop programmes in deliberation with the responsible ministries. France and the UK represent the latter type. All together, the 17 analysed countries funded biotechnology with about 10,000 MECU during the period 1994 to 1998. Based on the 17 country case studies, a European biotechnology funding map was constructed, indicating the significance of different biotechnology areas in the funding strategies of the considered countries. The emerging trends in funding of biotechnology areas in European countries indicate that all countries are setting clear priorities. These trends allow the following conclusions about the future picture of the European funding map: strong areas of today, and in particular human and veterinary biotechnology will keep their significance. In addition, the importance of basic biotechnology tools will be acknowledged by far more countries. On the other hand, the weak areas of nowadays will stay weak. Laufzeitbeginn: 01.11.1997 Laufzeitende: 28.02.1999 Förderung: European Commission, DG XII Durchführende Institution: Fraunhofer-Institut für Systemtechnik und Innovationsforschung (FhG-ISI), Karlsruhe http://www.isi.fhg.de/ TNO-STB, Apeldoorn (The Netherlands) http://www.stb.tno.nl/ SPRU, Brighton (United Kingdom) http://www.sussex.ac.uk/spru/ QAP Decision, Grenoble (France) INRA/SERD, Grenoble (France) http://www.upmf-grenoble.fr/inra/serd/ Kontakt Dr. Thomas Reiß Telefon: 0721 / 6809-160 Email: Thomas.Reiss@isi.fhg.de Datum des Eintrags: 28.02.1999 Zurück